Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
For this interview, we're joined by Rachael Drake, a pharmacy technician coordinator at the University of Kansas Health System. She works with the medication assistance team, helping uninsured and underinsured patients access drug manufacturer assistance programs and foundation support to cover the costs of their cancer treatments. Drake shares the significant challenges patients face when managing their non-Hodgkin lymphoma treatments, from navigating insurance coverage to affording the high costs of care. She explains how her team collaborates with insurance companies, pharmacists, nurses, and other providers to help patients get the coverage and financial assistance they need.
Drake also highlights the various support systems and resources available, from transportation and lodging assistance to survivorship programs and support groups. However, she notes that many patients are unaware these programs exist, emphasizing the importance of raising awareness to support patients throughout their treatment journey.
This episode of Managed Care Cast is part of the Frameworks for Advancing Health Equity podcast series from The American Journal of Managed Care® Center on Health Equity and Access, setting the stage for a deep dive into program initiatives across the US dedicated to mitigating health care disparities by closing the accessibility gap.
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More